A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/26/2002	US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002	US6486129 Antithrombotic compounds
11/26/2002	US6486125 Synthesis of soluble β-sheet forming peptides
11/26/2002	US6486124 Mixture of cyclosporin a and fatty ester
11/26/2002	US6486123 Low oxygen affinity mutant hemoglobins
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485977 Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems
11/26/2002	US6485976 Use of adeno-associated virus (AAV) to deliver genes
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485972 WNT signalling in reproductive organs
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485955 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
11/26/2002	US6485950 Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
11/26/2002	US6485942 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
11/26/2002	US6485939 Isolated human transporter cofactor proteins, nucleic acid molecules encoding human transporter cofactor proteins, and uses thereof
11/26/2002	US6485938 Nucleic acid molecules that encodes human Zven1
11/26/2002	US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485933 B cell receptor associated proteins
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485928 The t cell activation marker, granulysin for treating infections, including mycobacterium tuberculae
11/26/2002	US6485920 Growth factor antagonist materials and methods
11/26/2002	US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485910 Ras association domain containing protein
11/26/2002	US6485900 Synthetic antigen for the detection of AIDS-related disease
11/26/2002	US6485733 Absorbent article composition for sequestering skin irritants
11/26/2002	US6485726 Transepithelial delivery of antigens to provoke tolerance and immunity; the delivery of therapeutics conjugated to a fcrn binding partner to epithelium
11/26/2002	US6485720 Transgene expression systems
11/26/2002	US6485719 Methods for inhibiting angiogenesis with leukocyte adhesion inhibitor-1 (LAI-1) polypeptides
11/26/2002	US6485706 Dehydration product of insulin and an orally effective nonsteroidal membrane-permeation enhancer, for administration to buccal mucosa via spraying suspension of solid particles
11/26/2002	US6485704 Azo compound for type I pototherapy
11/26/2002	US6485480 Treatment methods using homeopathic preparations of growth factors
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2103580C Orthomolecular method of treating sickle cell disease
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/26/2002	CA2073734C Humane thrombine concentrate preparation process for therapeutic use
11/26/2002	CA2067901C Novel polypeptides with affinity to lipopolysaccharides and their uses
11/26/2002	CA2066913C Novel binding peptides
11/26/2002	CA1341401C Immunosuppressant factor derived from human glioblastoma cells
11/23/2002	CA2382443A1 Use of anti-ctla-4 antibodies
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002092855A1 Antisense modulation of helicase-moi expression
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092839A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/21/2002	WO2002092837A2 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092821A1 Novel maxizyme
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092805A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092787A2 Human secreted proteins
11/21/2002	WO2002092785A2 Composition and methods relating to ovarian specific genes and proteins
11/21/2002	WO2002092784A2 POLYNUCLEOTIDES AND POLYPEPTIDES RELATING TO THE MODULATION OF SIRP α-CD47
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	WO2002092772A2 Antisense modulation of ptp1b expression
11/21/2002	WO2002092768A2 Novel alanine transaminase enzyme and methods of use
11/21/2002	WO2002092765A2 Novel telomerase inhibitors and uses therefor
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092630A1 High density lipoprotein-reactive peptides
11/21/2002	WO2002092626A2 Cleavage and polyadenylation complex of precursor mrna
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092622A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors
11/21/2002	WO2002092621A1 Isolated human secreted proteins nucleic acid molecules encoding human secreted proteins and uses thereof
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092619A2 Modified growth hormone
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092616A1 Antisense permeation enhancers
11/21/2002	WO2002092566A1 Arginine derivatives
11/21/2002	WO2002092147A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/21/2002	WO2002092138A1 Methods and apparatus relating to treatment systems using light for the treatment of fluid products
11/21/2002	WO2002092129A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
11/21/2002	WO2002092128A1 Compositions and methods to regulate serum phosphate
11/21/2002	WO2002092127A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	WO2002092124A1 Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092121A1 Novel remedies for neurodegenerative disease
11/21/2002	WO2002092120A1 Structurally modified peptides and uses thereof
11/21/2002	WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	WO2002092117A1 Method and compositions for inhibiting thrombin-induced coagulation
11/21/2002	WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections
11/21/2002	WO2002092115A2 Method of preventing cell death using segments of neural thread proteins
11/21/2002	WO2002092069A1 Permeation enhancers
11/21/2002	WO2002092039A1 Methods for treating or preventing diseases of the oral cavity
11/21/2002	WO2002092032A1 Use of 3-position cyclosporin derivatives for hair growth
11/21/2002	WO2002092031A1 Topical compositions containing nonimmunosuppressive cyclosporin_derivatives for treating hair loss
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002092018A2 Methods for inducing sustained immune response

1 ... 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 ... 3163